🇺🇸 FDA
Pipeline program

AMOXICILLINE/ACIDE CLAVULANIQUE PANPHARMA 2 g/200 mg ADULTES, poudre pour solution injectable

APHP200011

Phase 3 small_molecule active

Quick answer

AMOXICILLINE/ACIDE CLAVULANIQUE PANPHARMA 2 g/200 mg ADULTES, poudre pour solution injectable for Intensive care, Ventilator Associated Pneumonia is a Phase 3 program (small_molecule) at Pari Pharma GmbH with 1 ClinicalTrials.gov record(s).

Program details

Company
Pari Pharma GmbH
Indication
Intensive care, Ventilator Associated Pneumonia
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials